Search tool

Displaying 1801 - 1810 of 4575

Barriers to HCV Testing in Drug Treatment Services for People who inject drugs

People who inject drugs (PWID) remain a key risk group for hepatitis C virus infection (HCV) with national prevalence estimates ranging from 13.8% (Malta) to 84.3% (Portugal) in Europe. To reach the...

EMCDDA at 7th International Symposium on Hepatitis Care in Substance Users

This week, the EMCDDA is participating in the 7th International Symposium on Hepatitis Care in Substance Users, organised by the International Network for Hepatitis in Substance Users (INHSU). The event, running from...

European evidence-based guidance on prevention and control of HCV in prison settings (poster)

In the 31 EU/EEA countries, more than 590 000 persons are held in a custodial facility on any given day. According to recent reviews of prison studies from EU countries, prison prevalence...

Document library

HCV policies landscape in Europe, 2018 – EMCDDA commissioned study (contract CT.16.IBS.0156.1.0)

In the context of its contribution to monitoring HCV elimination among PWID in Europe, the EMCDDA conducted a study on current HCV policies, assessing if and how these refer to people who...

Viral hepatitis policies in Europe (topic overview)

Hepatitis C virus (HCV) infection is the most common infectious disease in people who inject drugs, among whom it is usually transmitted through the sharing of syringes and other drug use equipment...

EMCDDA-IPA6 Mid-term coordination meeting

18.09.2018 to 16.09.2019

The objective of the EMCDDA-IPA6 Mid-term coordination meeting was to assess the state of progress of the project, as well as plan future activities for and to brainstorm about the IPA 7...

Skopje, North Macedonia

EMCDDA Director meets President of the European Forum for Urban Security

Director Alexis Goosdeel was in Belgium today where he met with Willy Demeyer, Mayor of Liège and currently President of the European Forum for Urban Security (EFUS). The purpose of the meeting...

Poster on Supporting capacity-building, analysis and threat assessment in Europe’s neighbourhood

Poster: Supporting capacity-building, analysis and threat assessment in Europe’s neighbourhood

Partnership is a guiding principle for the EMCDDA as it works to increase its understanding of the external dimension of the drug phenomenon and its implications for public health and security in...

Document library

EU–ANSA agencies’ engagement in the European Union research knowledge cycle: an overview

The European Union Agencies Network for Scientific Advice (EU–ANSA) consists of technical and regulatory agencies that provide scientific advice to EU policymakers; these agencies are thus both a source and a user...

Document library

Bosnia and Herzegovina National Strategy on the Supervision of Narcotic Drugs, Prevention and Suppression of Abuse of Narcotic Drugs, 2018– 2023